Adapt Pharma to freeze public interest price of overdose drug

This article states that pharmaceutical company Adapt Pharma is going to keep the price of a lifesaving drug from increasing in the state of Ohio. The drug naxolone, a nasal spray that when given to someone overdosing, can save their life. However, the cost has prevented agencies from carrying it as a potential method to help someone.  

This announcement came from the Ohio State General Attorney Mike DeWine on November 25:  

The naxalone spray can be given to people overdosing on opioids such as heroin, fentanyl, carfentanil or prescription opioid.

DeWine met with Adapt Pharma last week on a proposal to offer the spray to Ohio law enforcement, first responders, state and local government agencies and community-based organizations at a discounted rate over the next year. For the next year, qualified purchasers can buy two 4 mg doses of the nasal spray for $75.

Image via Legal NewsLine

“Overcoming the opioid epidemic requires all those affected by substance abuse disorder to have a second chance at recovery and life, which NARCAN® Nasal Spray can provide,” said Mike Kelly, president of U.S. operations at Adapt Pharma. "Our public interest price offers affordable access to this ideal formulation of naloxone and helps to educate those on the front lines of this public health crisis on the importance of this medication.”

I hope more drug companies follow suit to allow agencies that on first on the scene to be able to have this life saving drug on hand. It seems to be a way to give them an individual a second chance when they are going into respiratory failure or central nervous system depression.

Read the full post here:  http://legalnewsline.com/stories/511050281-adapt-pharma-to-freeze-public-interest-price-of-overdose-drug